News

Psychological Therapies Eased IBS for at Least 6-12 Months

Author and Disclosure Information

Key clinical point: A meta-analysis found that psychotherapy improved gastrointestinal symptoms in irritable bowel syndrome, with the effects persisting for at least 6-12 months.

Major finding: Immediately after treatment, the Cohen’s d value was 0.69 (P less than .001), indicating a medium effect size. Cohen’s d values were 0.76 and 0.73, respectively, at 1- to 6-month follow-up and at 6- to 12-month follow-up.

Data source: A systematic review and meta-analysis of 41 randomized controlled trials that included 2,290 patients with IBS.

Disclosures: The authors reported no funding sources and had no disclosures.

View on the News

Increase use of and access to psychotherapy for IBS patients

It is well established that psychological therapy is efficacious in managing irritable bowel syndrome (IBS), and it has an associated number needed to treat of four (Am J Gastroenterol. 2014 Sep;109:1350-65). A new meta-analysis from Laird and her colleagues revealed that the positive impact of psychotherapy on IBS symptoms persisted even 1 year after treatment.

Dr. Christopher Almario

While these findings are impressive and continue to support the use of psychotherapy in IBS, important issues remain. First, these results are based on data gathered in the highly controlled environment of randomized controlled trials (RCTs), and it is unclear whether they will translate to the “real world.” RCT participants may be more willing to complete psychotherapy because they know they are being observed by research staff (referred to as the Hawthorne, or observer, effect). However, in real clinical practice, patients with IBS not subject to the Hawthorne effect may be less compliant with such therapies.

Other issues relate to the current limited adoption of psychotherapy in clinical practice. Factors contributing to the low uptake include variable third-party reimbursement and poor patient and provider acceptance (JAMA. 2015 Mar;313:949-58). Another factor is limited access to qualified psychotherapists. This is an area where telehealth and mobile apps can widen access, especially as Internet-delivered psychotherapy has been shown to be effective (Am J Gastroenterol. 2011;106:1481-91).

Given the high prevalence of IBS, along with the proven, persistent efficacy of psychological therapies in reducing IBS symptoms, efforts to increase both use of and access to these therapies in clinical practice are needed.

Dr. Christopher V. Almario, division of gastroenterology, Cedars-Sinai Medical Center, Los Angeles. He has no relevant conflicts of interest to declare.


 

FROM CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

References

Adults with irritable bowel syndrome (IBS) who underwent psychotherapy improved more than about 75% of controls, and the effect “remained significant and medium in magnitude” for at least 6-12 months, according to a meta-analysis of 41 randomized, controlled trials reported in the July issue of Clinical Gastroenterology and Hepatology.

The finding “is particularly noteworthy because of the typically recurrent, persistent nature of IBS symptoms,” said Kelsey Laird, a doctoral student of clinical psychology at Vanderbilt University in Nashville, Tenn., together with her associates there. “Future research is needed to compare the longevity of treatment effects for psychotherapy with pharmacologic therapies, such as antidepressants,” they added. “Although it is beyond the scope of this review, it is also important to consider the mechanisms by which psychotherapies improve GI symptoms and to determine the ‘active ingredients’ responsible for this effect.”

©MacXever/Thinkstock

Up to 16% of individuals in the United States have IBS, and treating it costs anywhere from $950 million to $1.35 billion per year, the researchers noted. Other meta-analyses found psychotherapy about as effective as antidepressants for treating IBS-related GI symptoms over the short term, but its long-term efficacy was unknown, they added. Therefore, they searched PubMed, PsycINFO, Science Direct, and ProQuest through Aug. 15, 2015, identifying randomized controlled trials of psychological therapy and active or nonactive comparators. Psychotherapy included not only traditional psychodynamic and cognitive-behavioral therapies, but also mind-body approaches, such as relaxation training, biofeedback, and yoga, “which can be conceptualized as mindful movement,” Ms. Laird and her associates said. Comparators included support groups, education, sham treatments for hypnosis or biofeedback, online discussion forums, enhanced medical care, treatment as usual, symptom monitoring, and being wait-listed for psychological treatment (Clin Gastroenterol Hepatol. 2016 Jan 21. doi: 10.1016/j.cgh.2015.11.020). The 41 trials included 2,290 patients, comprising 1,183 assigned to the psychological modalities and 1,107 assigned to the various comparators. Taken together, the psychological modalities were associated with greater improvements in GI symptoms immediately after treatment, as compared with the grouped comparators. The Cohen’s d value was 0.69 (95% confidence interval, 0.52-0.86; P less than .001), indicating a medium effect size, the researchers said. Moreover, Cohen’s d values were 0.76 and 0.73, respectively, at short-term follow-up (1-6 months) and long-term follow-up (6-12 months). “On average, individuals who received psychotherapy had a greater reduction in GI symptoms after treatment than 75% of individuals assigned to a control condition,” the researchers concluded.

Effect sizes were similar among cognitive, cognitive-behavioral, and relaxation and hypnosis interventions, and between interventions delivered online and in person, the investigators also reported. Furthermore, longer durations or sessions of psychotherapy did not appear to further improve symptoms.

Study limitations included substantial variability between trials, and the fact that none of the 41 trials could be seen as having a low risk of bias in every domain assessed, the investigators said. “This was partially a result of the difficulty in blinding participants in psychological trials,” they noted. “However, even after excluding this domain, only nine trials were rated as low risk of bias in all remaining domains. Future studies should follow the CONSORT guidelines for [randomized controlled trials], use [intention-to-treat] designs, use active control conditions to control for nonspecific treatment effects, and assess treatment credibility and expectancy.”

The authors reported no funding sources and had no disclosures.

Recommended Reading

High Gluten Consumption Early in Life Upped Risk for Celiac Disease
Clinician Reviews
Birth-cohort HCV Testing Misses One-quarter of Infections
Clinician Reviews
Test All Kidney Transplant Patients for Hepatitis E
Clinician Reviews
Minor Residual Staining Found Adequate for Colonoscopy
Clinician Reviews
April 2016: Click for Credit
Clinician Reviews
Risk for IBD Doubled in Hidradenitis Suppurativa
Clinician Reviews
Study Describes Women’s Autoimmune Disease Burden
Clinician Reviews
PPI Cuts GI Events From Low- and High-dose Aspirin
Clinician Reviews
As Preventive, H2RA Poses Risks for Patients on Clopidogrel After Bleeding Ulcer
Clinician Reviews
Seasonal Variation Not Seen in C difficile Rates
Clinician Reviews